Below, we present the role of the PD-L1 pathway in cancer immune evasion, the role of RKIP in anti-tumor immune activation, the signaling cross-talks between RKIP and PD-L1 expressions, and targeted therapeutic strategies to avoid immune evasion. The gene discussed is PEBP1; the disease is neoplasm.